Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2005 1
2006 2
2007 1
2008 1
2011 1
2012 1
2013 1
2014 1
2015 3
2016 2
2017 4
2018 3
2019 6
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines.
Cerchia C, Nasso R, Mori M, Villa S, Gelain A, Capasso A, Aliotta F, Simonetti M, Rullo R, Masullo M, De Vendittis E, Ruocco MR, Lavecchia A. Cerchia C, et al. Among authors: gelain a. J Med Chem. 2019 Aug 8;62(15):7089-7110. doi: 10.1021/acs.jmedchem.9b00632. Epub 2019 Jul 24. J Med Chem. 2019. PMID: 31294975
Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives.
Ehrsam D, Porta F, Mori M, Schwabedissen HEMZ, Dalla Via L, Garcia-Argaez AN, Basile L, Meneghetti F, Villa S, Gelain A. Ehrsam D, et al. Among authors: gelain a. Anticancer Res. 2019 Jul;39(7):3453-3461. doi: 10.21873/anticanres.13491. Anticancer Res. 2019. PMID: 31262869 Free article.
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis.
Mori M, Sammartino JC, Costantino L, Gelain A, Meneghetti F, Villa S, Chiarelli LR. Mori M, et al. Among authors: gelain a. Curr Top Med Chem. 2019;19(9):646-661. doi: 10.2174/1568026619666190227182701. Curr Top Med Chem. 2019. PMID: 30827246 Review.
Iron Acquisition Pathways as Targets for Antitubercular Drugs.
Meneghetti F, Villa S, Gelain A, Barlocco D, Chiarelli LR, Pasca MR, Costantino L. Meneghetti F, et al. Among authors: gelain a. Curr Med Chem. 2016;23(35):4009-4026. doi: 10.2174/0929867323666160607223747. Curr Med Chem. 2016. PMID: 27281295 Review.
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
Chiarelli LR, Mori M, Barlocco D, Beretta G, Gelain A, Pini E, Porcino M, Mori G, Stelitano G, Costantino L, Lapillo M, Bonanni D, Poli G, Tuccinardi T, Villa S, Meneghetti F. Chiarelli LR, et al. Among authors: gelain a. Eur J Med Chem. 2018 Jul 15;155:754-763. doi: 10.1016/j.ejmech.2018.06.033. Epub 2018 Jun 18. Eur J Med Chem. 2018. PMID: 29940465 Free article.
Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors.
Villa S, Legnani L, Colombo D, Gelain A, Lammi C, Bongiorno D, Ilboudo DP, McGee KE, Bosch J, Grazioso G. Villa S, et al. Among authors: gelain a. J Comput Aided Mol Des. 2018 Mar;32(3):473-486. doi: 10.1007/s10822-018-0102-5. Epub 2018 Jan 30. J Comput Aided Mol Des. 2018. PMID: 29383466 Free article.
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies.
Pini E, Poli G, Tuccinardi T, Chiarelli LR, Mori M, Gelain A, Costantino L, Villa S, Meneghetti F, Barlocco D. Pini E, et al. Among authors: gelain a. Molecules. 2018 Jun 21;23(7):1506. doi: 10.3390/molecules23071506. Molecules. 2018. PMID: 29933627 Free PMC article.
Mycobacterium tuberculosis Low Molecular Weight Phosphatases (MPtpA and MPtpB): From Biological Insight to Inhibitors.
Fanzani L, Porta F, Meneghetti F, Villa S, Gelain A, Lucarelli AP, Parisini E. Fanzani L, et al. Among authors: gelain a. Curr Med Chem. 2015;22(27):3110-32. doi: 10.2174/0929867322666150812150036. Curr Med Chem. 2015. PMID: 26264920 Review.
Exploring the Biological Activity of a Library of 1,2,5-Oxadiazole Derivatives Endowed With Antiproliferative Activity.
Gelain A, Mori M, Meneghetti F, Porta F, Basile L, Marverti G, Asai A, Hyeraci M, García-Argáez AN, Via LD, Guccione S, Villa S. Gelain A, et al. Anticancer Res. 2019 Jan;39(1):135-144. doi: 10.21873/anticanres.13089. Anticancer Res. 2019. PMID: 30591450
31 results
Jump to page